Liu YK - Search Results

1

A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values.

Jin GZ, Dong H, Yu WL, Li Y, Lu XY, Yu H, Xian ZH, Dong W, Liu YK, Cong WM, Wu MC. Jin GZ, et al. Among authors: liu yk. BMC Cancer. 2013 Mar 27;13:161. doi: 10.1186/1471-2407-13-161. BMC Cancer. 2013. PMID: 23537217 Free PMC article.

2

iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma.

Jin GZ, Li Y, Cong WM, Yu H, Dong H, Shu H, Liu XH, Yan GQ, Zhang L, Zhang Y, Kang XN, Guo K, Wang ZD, Yang PY, Liu YK. Jin GZ, et al. Among authors: liu xh, liu yk. J Proteome Res. 2011 Aug 5;10(8):3418-28. doi: 10.1021/pr200482t. Epub 2011 Jun 21. J Proteome Res. 2011. PMID: 21631109

3

SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.

Jin GZ, Yu WL, Dong H, Zhou WP, Gu YJ, Yu H, Yu H, Lu XY, Xian ZH, Liu YK, Cong WM, Wu MC. Jin GZ, et al. Among authors: liu yk. J Hepatol. 2013 Sep;59(3):510-7. doi: 10.1016/j.jhep.2013.04.028. Epub 2013 May 9. J Hepatol. 2013. PMID: 23665285

4

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.

Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y. Wang C, et al. BMC Cancer. 2012 May 4;12:166. doi: 10.1186/1471-2407-12-166. BMC Cancer. 2012. PMID: 22559167 Free PMC article.

5

Autoantibody signature in hepatocellular carcinoma using seromics.

Zhang S, Liu Y, Chen J, Shu H, Shen S, Li Y, Lu X, Cao X, Dong L, Shi J, Cao Y, Wang X, Zhou J, Liu Y, Chen L, Fan J, Ding G, Gao Q. Zhang S, et al. J Hematol Oncol. 2020 Jul 2;13(1):85. doi: 10.1186/s13045-020-00918-x. J Hematol Oncol. 2020. PMID: 32616055 Free PMC article.

6

[Identification of metastasis-related osteopontin expression and glycosylation in hepatocellular carcinoma].

Sun HY, Li Y, Guo K, Kang XN, Sun C, Liu YK. Sun HY, et al. Among authors: liu yk. Zhonghua Gan Zang Bing Za Zhi. 2011 Dec;19(12):904-7. doi: 10.3760/cma.j.issn.1007-3418.2011.12.006. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22525502 Chinese.

7

[Applicability of the multiplex quantitative antibody array system for early diagnosis of hepatocellular carcinoma].

Gao DM, Sun L, Guo K, Li Y, Liu YK, Kang XN. Gao DM, et al. Among authors: liu yk. Zhonghua Gan Zang Bing Za Zhi. 2012 Oct;20(10):785-8. doi: 10.3760/cma.j.issn.1007-3418.2012.10.016. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23207342 Chinese.

8

Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug.

Sun C, Sun L, Li Y, Kang X, Zhang S, Liu Y. Sun C, et al. Med Oncol. 2013 Jun;30(2):503. doi: 10.1007/s12032-013-0503-1. Epub 2013 Feb 21. Med Oncol. 2013. PMID: 23430442 Clinical Trial.

9

[Inhibitory effects of a novel trimeric of beta peptide (beta3) on migration and invasion of hepatocellular carcinoma cells].

Wang SM, Zhu J, Li Y, Pan LF, Zha XL, Liu YK. Wang SM, et al. Among authors: liu yk. Zhonghua Gan Zang Bing Za Zhi. 2005 Jul;13(7):541-2. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16042898 Chinese. No abstract available.

10

Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.

Wang C, Guo K, Gao D, Kang X, Jiang K, Li Y, Sun L, Zhang S, Sun C, Liu X, Wu W, Yang P, Liu Y. Wang C, et al. Cancer Lett. 2011 Dec 27;313(2):154-66. doi: 10.1016/j.canlet.2011.08.031. Epub 2011 Oct 8. Cancer Lett. 2011. PMID: 22023829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

561 results

Search Page

Filters